Sol-Gel Technologies Beheer
Beheer criteriumcontroles 3/4
We currently do not have sufficient information about the CEO.
Belangrijke informatie
Alon Seri-Levy
Algemeen directeur
US$1.2m
Totale compensatie
| Percentage CEO-salaris | 27.1% |
| Dienstverband CEO | 27.8yrs |
| Eigendom CEO | n/a |
| Management gemiddelde ambtstermijn | 8.2yrs |
| Gemiddelde ambtstermijn bestuur | 6.8yrs |
Recente managementupdates
Recent updates
Will Sol-Gel Technologies (NASDAQ:SLGL) Spend Its Cash Wisely?
Feb 28
Here's Why We're Watching Sol-Gel Technologies' (NASDAQ:SLGL) Cash Burn Situation
Nov 07Companies Like Sol-Gel Technologies (NASDAQ:SLGL) Are In A Position To Invest In Growth
Jul 21Sol-Gel Technologies GAAP EPS of $0.01 beats by $0.11, revenue of $3.5M misses by $1.11M
Aug 04These Analysts Think Sol-Gel Technologies Ltd.'s (NASDAQ:SLGL) Sales Are Under Threat
May 17We Think That There Are Issues Underlying Sol-Gel Technologies' (NASDAQ:SLGL) Earnings
Apr 15Downgrade: Here's How Analysts See Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Performing In The Near Term
Apr 05We Think Sol-Gel Technologies (NASDAQ:SLGL) Can Afford To Drive Business Growth
Nov 23We Think Sol-Gel Technologies (NASDAQ:SLGL) Needs To Drive Business Growth Carefully
Aug 04Here's Why Sol-Gel Technologies Ltd.'s (NASDAQ:SLGL) CEO May Deserve A Raise
Jul 01Sol-Gel says no FDA notification regarding its marketing application for EPSOLAY
Apr 27Newsflash: Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Analysts Have Been Trimming Their Revenue Forecasts
Mar 05We're Not Very Worried About Sol-Gel Technologies' (NASDAQ:SLGL) Cash Burn Rate
Feb 02What Type Of Returns Would Sol-Gel Technologies'(NASDAQ:SLGL) Shareholders Have Earned If They Purchased Their SharesYear Ago?
Dec 29
FDA accepts Sol-Gel application for Twyneo
Dec 07Sol-Gel: Slow And Steady Topical Technology
Nov 19These Analysts Think Sol-Gel Technologies Ltd.'s (NASDAQ:SLGL) Sales Are Under Threat
Nov 18Sol-Gel Technologies EPS beats by $0.09, beats on revenue
Nov 12Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$15m |
| Mar 31 2024 | n/a | n/a | -US$23m |
| Dec 31 2023 | US$1m | US$325k | -US$27m |
| Sep 30 2023 | n/a | n/a | -US$28m |
| Jun 30 2023 | n/a | n/a | -US$26m |
| Mar 31 2023 | n/a | n/a | -US$20m |
| Dec 31 2022 | US$1m | US$323k | -US$15m |
| Sep 30 2022 | n/a | n/a | US$5m |
| Jun 30 2022 | n/a | n/a | US$10m |
| Mar 31 2022 | n/a | n/a | US$2m |
| Dec 31 2021 | US$639k | US$334k | US$3m |
| Sep 30 2021 | n/a | n/a | -US$17m |
| Jun 30 2021 | n/a | n/a | -US$27m |
| Mar 31 2021 | n/a | n/a | -US$26m |
| Dec 31 2020 | US$636k | US$314k | -US$29m |
| Sep 30 2020 | n/a | n/a | -US$29m |
| Jun 30 2020 | n/a | n/a | -US$28m |
| Mar 31 2020 | n/a | n/a | -US$26m |
| Dec 31 2019 | US$1m | US$303k | -US$25m |
| Sep 30 2019 | n/a | n/a | -US$30m |
| Jun 30 2019 | n/a | n/a | -US$30m |
| Mar 31 2019 | n/a | n/a | -US$32m |
| Dec 31 2018 | US$1m | US$294k | -US$32m |
| Sep 30 2018 | n/a | n/a | -US$26m |
| Jun 30 2018 | n/a | n/a | -US$32m |
| Mar 31 2018 | n/a | n/a | -US$32m |
| Dec 31 2017 | US$1m | US$223k | -US$32m |
Compensatie versus markt: Alon's total compensation ($USD1.20M) is above average for companies of similar size in the US market ($USD655.65K).
Compensatie versus inkomsten: Alon's compensation has been consistent with company performance over the past year.
CEO
Alon Seri-Levy (63 yo)
27.8yrs
Tenure
US$1,198,000
Compensatie
Dr. Alon Seri-Levy is a Co-Founder at Sol-Gel Technologies Ltd. in 1997 and has been its Chief Executive Officer since 1997. Dr. Seri-Levy established the computer-aided drug design department at Peptor Lt...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Co-Founder | 27.8yrs | US$1.20m | geen gegevens | |
| Chief Operating Officer | 8.3yrs | US$288.00k | geen gegevens | |
| Advisor | less than a year | US$643.00k | geen gegevens | |
| Executive Chairman of the Board | 10.8yrs | geen gegevens | 65.17% $ 9.3m | |
| Co-Founder | 27.8yrs | geen gegevens | geen gegevens | |
| Chief Financial Officer | less than a year | geen gegevens | geen gegevens | |
| VP & General Counsel | 1.7yrs | geen gegevens | geen gegevens | |
| VP of Projects & Planning and Chief Chemist | 8.2yrs | geen gegevens | geen gegevens |
8.2yrs
Gemiddelde duur
54.5yo
Gemiddelde leeftijd
Ervaren management: SLGL's management team is seasoned and experienced (8.2 years average tenure).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Co-Founder | 6.8yrs | US$1.20m | geen gegevens | |
| Executive Chairman of the Board | 10.8yrs | geen gegevens | 65.17% $ 9.3m | |
| Lead Independent Director | 6.8yrs | geen gegevens | geen gegevens | |
| Director | 6.8yrs | geen gegevens | geen gegevens | |
| Independent Director | 6.2yrs | geen gegevens | geen gegevens | |
| Director | 6.8yrs | geen gegevens | geen gegevens | |
| Director | 1.3yrs | geen gegevens | geen gegevens | |
| Independent External Director | less than a year | geen gegevens | geen gegevens |
6.8yrs
Gemiddelde duur
59yo
Gemiddelde leeftijd
Ervaren bestuur: SLGL's board of directors are considered experienced (6.8 years average tenure).